Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI.

Mehralivand S, Shih JH, Harmon S, Smith C, Bloom J, Czarniecki M, Gold S, Hale G, Rayn K, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B.

Radiology. 2019 Mar;290(3):709-719. doi: 10.1148/radiol.2018181278. Epub 2019 Jan 22.

PMID:
30667329
2.

Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical Prostatectomy.

Nyarangi-Dix J, Wiesenfarth M, Bonekamp D, Hitthaler B, Schütz V, Dieffenbacher S, Mueller-Wolf M, Roth W, Stenzinger A, Duensing S, Roethke M, Teber D, Schlemmer HP, Hohenfellner M, Radtke JP.

Eur Urol Focus. 2018 Nov 23. pii: S2405-4569(18)30336-5. doi: 10.1016/j.euf.2018.11.004. [Epub ahead of print]

PMID:
30477971
3.

Length of capsular contact for diagnosing extraprostatic extension on prostate MRI: Assessment at an optimal threshold.

Rosenkrantz AB, Shanbhogue AK, Wang A, Kong MX, Babb JS, Taneja SS.

J Magn Reson Imaging. 2016 Apr;43(4):990-7. doi: 10.1002/jmri.25040. Epub 2015 Sep 23.

PMID:
26395278
4.

Evaluation of MRI for diagnosis of extraprostatic extension in prostate cancer.

Krishna S, Lim CS, McInnes MDF, Flood TA, Shabana WM, Lim RS, Schieda N.

J Magn Reson Imaging. 2018 Jan;47(1):176-185. doi: 10.1002/jmri.25729. Epub 2017 Apr 7.

PMID:
28387981
5.

Prostate Cancer: The European Society of Urogenital Radiology Prostate Imaging Reporting and Data System Criteria for Predicting Extraprostatic Extension by Using 3-T Multiparametric MR Imaging.

Kayat Bittencourt L, Litjens G, Hulsbergen-van de Kaa CA, Turkbey B, Gasparetto EL, Barentsz JO.

Radiology. 2015 Aug;276(2):479-89. doi: 10.1148/radiol.15141412. Epub 2015 Apr 3.

PMID:
25848900
6.

Evaluation of the most optimal multiparametric magnetic resonance imaging sequence for determining pathological length of capsular contact.

Onay A, Vural M, Armutlu A, Ozel Yıldız S, Kiremit MC, Esen T, Bakır B.

Eur J Radiol. 2019 Mar;112:192-199. doi: 10.1016/j.ejrad.2019.01.020. Epub 2019 Jan 22.

PMID:
30777210
7.

Diagnostic Utility of a Likert Scale Versus Qualitative Descriptors and Length of Capsular Contact for Determining Extraprostatic Tumor Extension at Multiparametric Prostate MRI.

Costa DN, Passoni NM, Leyendecker JR, de Leon AD, Lotan Y, Roehrborn CG, Otero-Muinelo S, Grewal H, Xi Y, Francis F, Rofsky NM, Pedrosa I.

AJR Am J Roentgenol. 2018 May;210(5):1066-1072. doi: 10.2214/AJR.17.18849. Epub 2018 Feb 28.

PMID:
29489410
8.

Prostate Imaging Reporting and Data System, Version 2, Assessment Categories and Pathologic Outcomes in Patients With Gleason Score 3 + 4 = 7 Prostate Cancer Diagnosed at Biopsy.

Lim CS, McInnes MDF, Flood TA, Breau RH, Morash C, Thornhill RE, Schieda N.

AJR Am J Roentgenol. 2017 May;208(5):1037-1044. doi: 10.2214/AJR.16.16843. Epub 2017 Mar 7.

PMID:
28267359
9.

The relationship between the extent of extraprostatic extension and survival following radical prostatectomy.

Jeong BC, Chalfin HJ, Lee SB, Feng Z, Epstein JI, Trock BJ, Partin AW, Humphreys E, Walsh PC, Han M.

Eur Urol. 2015 Feb;67(2):342-6. doi: 10.1016/j.eururo.2014.06.015. Epub 2014 Jun 23.

PMID:
24968968
10.

Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.

Tosoian JJ, Chappidi M, Feng Z, Humphreys EB, Han M, Pavlovich CP, Epstein JI, Partin AW, Trock BJ.

BJU Int. 2017 May;119(5):676-683. doi: 10.1111/bju.13573. Epub 2016 Jul 29.

11.

Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.

Kumar A, Samavedi S, Mouraviev V, Bates AS, Coelho RF, Rocco B, Patel VR.

J Robot Surg. 2017 Mar;11(1):37-45. doi: 10.1007/s11701-016-0606-8. Epub 2016 May 31.

PMID:
27245233
12.

The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.

Somford DM, Hamoen EH, Fütterer JJ, van Basten JP, Hulsbergen-van de Kaa CA, Vreuls W, van Oort IM, Vergunst H, Kiemeney LA, Barentsz JO, Witjes JA.

J Urol. 2013 Nov;190(5):1728-34. doi: 10.1016/j.juro.2013.05.021. Epub 2013 May 13.

PMID:
23680307
13.

Detection of extraprostatic disease and seminal vesicle invasion in patients undergoing magnetic resonance imaging-targeted prostate biopsies.

Baumgartner EM, Porter KK, Nix JW, Rais-Bahrami S, Gordetsky JB.

Transl Androl Urol. 2018 Sep;7(Suppl 4):S392-S396. doi: 10.21037/tau.2018.03.15.

14.

Evaluation of apparent diffusion coefficient and MR volumetry as independent associative factors for extra-prostatic extension (EPE) in prostatic carcinoma.

Lim C, Flood TA, Hakim SW, Shabana WM, Quon JS, El-Khodary M, Thornhill RE, El Hallani S, Schieda N.

J Magn Reson Imaging. 2016 Mar;43(3):726-36. doi: 10.1002/jmri.25033. Epub 2015 Aug 25.

PMID:
26303719
15.
16.

Prediction of extraprostatic extension by MRI tumor contact length: difference between anterior and posterior prostate cancer.

Matsumoto K, Akita H, Narita K, Hashiguchi A, Takamatsu K, Takeda T, Kosaka T, Mizuno R, Kikuchi E, Oya M, Jinzaki M.

Prostate Cancer Prostatic Dis. 2019 Feb 27. doi: 10.1038/s41391-019-0136-3. [Epub ahead of print]

PMID:
30814680
17.

Prostate Cancer: Utility of Whole-Lesion Apparent Diffusion Coefficient Metrics for Prediction of Biochemical Recurrence After Radical Prostatectomy.

Rosenkrantz AB, Ream JM, Nolan P, Rusinek H, Deng FM, Taneja SS.

AJR Am J Roentgenol. 2015 Dec;205(6):1208-14. doi: 10.2214/AJR.15.14482.

18.

Diagnostic Performance of Prospectively Assigned Likert Scale Scores to Determine Extraprostatic Extension and Seminal Vesicle Invasion With Multiparametric MRI of the Prostate.

Freifeld Y, Diaz de Leon A, Xi Y, Pedrosa I, Roehrborn CG, Lotan Y, Francis F, Costa DN.

AJR Am J Roentgenol. 2019 Mar;212(3):576-581. doi: 10.2214/AJR.18.20320. Epub 2018 Dec 27.

PMID:
30589381
19.

Integration of MRI to clinical nomogram for predicting pathological stage before radical prostatectomy.

Lebacle C, Roudot-Thoraval F, Moktefi A, Bouanane M, De La Taille A, Salomon L.

World J Urol. 2017 Sep;35(9):1409-1415. doi: 10.1007/s00345-016-1981-5. Epub 2016 Dec 19.

PMID:
27995303
20.

Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: implications for prostate brachytherapy.

Pugh TJ, Frank SJ, Achim M, Kuban DA, Lee AK, Hoffman KE, McGuire SE, Swanson DA, Kudchadker R, Davis JW.

Brachytherapy. 2013 May-Jun;12(3):204-9. doi: 10.1016/j.brachy.2011.12.013. Epub 2012 Jun 5.

Supplemental Content

Support Center